Fluvoxamine and Omeprazole Interaction

Understanding the Fluvoxamine and Omeprazole Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Fluvoxamine belongs to the Selective Serotonin Reuptake Inhibitor (SSRI) class and Omeprazole belongs to the Proton Pump Inhibitor (PPI) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Fluvoxamine blocks the liver enzymes that are responsible for breaking down omeprazole. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Fluvoxamine has 40 total documented interactions on file in this dataset, and Omeprazole has 27. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may need to adjust your omeprazole dose or monitor you for side effects while you are taking both medications. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Fluvoxamine or Omeprazole based on a web page, speak with your prescriber or pharmacist before making any change.